bf/NASDAQ:MRNS_icon.jpeg

NASDAQ:MRNS

Marinus Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.40

30/08 20:00

Market Cap

67.57M

Beta: 1.16

Volume Today

413.06K

Avg: 544.92K

PE Ratio

−4.02

PFCF: −4.81

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.72M
-
15.35M
793.19%
25.48M
66.03%
30.99M
21.63%
cost of revenue
503K
-
50.51M
9,940.95%
1.48M
97.07%
340K
77.00%
2.48M
630.88%
gross profit
-503K
-
-48.79M
9,599.40%
13.87M
128.42%
25.14M
81.28%
28.50M
13.39%
selling and marketing expenses
general and administrative expenses
1.23M
-
3.23M
162.88%
5.52M
70.77%
6.24M
13.07%
6.67M
6.89%
8.79M
31.77%
11.46M
30.40%
18.55M
61.92%
37.28M
100.97%
selling general and administrative expenses
1.23M
-
3.23M
162.88%
5.52M
70.77%
6.24M
13.07%
6.67M
6.89%
8.79M
31.77%
11.46M
30.40%
18.55M
61.92%
37.28M
100.97%
56.84M
52.49%
61.15M
7.58%
research and development expenses
4.15M
-
8.69M
109.39%
18.92M
117.68%
22.00M
16.33%
12.38M
43.76%
28.39M
129.43%
42.97M
51.32%
51.11M
18.95%
73.52M
43.86%
79.91M
8.69%
98.84M
23.68%
other expenses
152.69K
-
1.19M
680.69%
-7K
100.59%
-65K
828.57%
-20K
69.23%
-1K
95%
-53K
5,200%
-37K
30.19%
657K
1,875.68%
1.17M
77.93%
-2.68M
328.91%
cost and expenses
5.35M
-
11.92M
122.76%
24.43M
104.97%
28.24M
15.59%
19.04M
32.57%
37.18M
95.24%
54.42M
46.38%
69.66M
27.99%
112.28M
61.19%
138.27M
23.15%
162.47M
17.51%
operating expenses
5.35M
-
11.92M
122.76%
24.43M
104.97%
28.24M
15.59%
19.04M
32.57%
37.18M
95.24%
54.42M
46.38%
69.66M
27.99%
110.80M
59.07%
137.93M
24.48%
159.99M
16.00%
interest expense
90.61K
-
117K
29.12%
475K
305.98%
464K
2.32%
159K
65.73%
2.58M
-
10.67M
313.32%
16.89M
58.31%
ebitda
-5.17M
-
-10.71M
107.20%
-24.36M
127.47%
-28.16M
15.56%
-18.74M
33.45%
-36.60M
95.31%
-54.14M
47.94%
-67.94M
25.47%
-96.19M
41.59%
-5.75M
94.02%
-130.93M
2,175.13%
operating income
-5.38M
-
-11.92M
121.61%
-24.43M
104.97%
-28.24M
15.59%
-19.04M
32.57%
-37.18M
95.24%
-54.42M
46.38%
-67.94M
24.83%
-96.93M
42.68%
-112.79M
16.36%
-131.49M
16.58%
depreciation and amortization
9.79K
-
5K
48.93%
11K
120%
23K
109.09%
126K
447.83%
127K
0.79%
278K
118.90%
334K
20.14%
737K
120.66%
107.03M
14,422.80%
551K
99.49%
total other income expenses net
152.69K
-
1.19M
680.69%
-7K
100.59%
-65K
828.57%
-20K
69.23%
-1K
95%
301K
30,200%
462K
53.49%
-1.84M
499.35%
96.36M
5,322.82%
-11.46M
111.89%
income before tax
-5.27M
-
-10.83M
105.57%
-24.85M
129.39%
-28.64M
15.26%
-18.90M
34.02%
-36.73M
94.34%
-54.12M
47.36%
-67.47M
24.67%
-98.78M
46.39%
-16.43M
83.37%
-142.94M
770.17%
income tax expense
-27.82K
-
1.31M
4,805.76%
468K
64.25%
399K
14.74%
13K
96.74%
453K
3,384.62%
-354K
178.15%
-833K
135.31%
2.88M
446.22%
3.39M
17.51%
-1.54M
145.38%
net income
-5.27M
-
-10.83M
105.57%
-24.85M
129.39%
-28.64M
15.26%
-18.90M
34.02%
-36.73M
94.34%
-53.77M
46.40%
-66.64M
23.95%
-101.66M
52.55%
-19.82M
80.51%
-141.41M
613.59%
weighted average shs out
2.02M
-
1.54M
23.70%
3.73M
142.49%
4.87M
30.69%
5.89M
20.73%
10.22M
73.72%
13.63M
33.30%
27.27M
100.10%
36.70M
34.57%
39.07M
6.47%
53.75M
37.56%
weighted average shs out dil
2.02M
-
1.54M
23.70%
3.73M
142.49%
4.87M
30.69%
5.89M
20.73%
10.22M
73.72%
13.63M
33.30%
27.27M
100.10%
36.70M
34.57%
39.07M
6.47%
53.75M
37.56%
eps
-2.61
-
-7.04
169.73%
-6.66
5.40%
-5.88
11.71%
-3.21
45.41%
-3.59
11.84%
-3.95
10.03%
-2.44
38.23%
-2.77
13.52%
-0.51
81.59%
-2.63
415.69%
epsdiluted
-2.61
-
-7.04
169.73%
-6.66
5.40%
-5.88
11.71%
-3.21
45.41%
-3.59
11.84%
-3.95
10.03%
-2.44
38.23%
-2.77
13.52%
-0.51
81.59%
-2.63
415.69%

All numbers in USD (except ratios and percentages)